Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The Prognostic Impact of Tumor Size and BRAF Mutational Status in Middle Eastern Differentiated Thyroid Cancer

17 Oct 2024

Abstract excerpt

CONTEXT: Tumor size at diagnosis has been widely used as a major mortality risk factor in risk stratification of differentiated thyroid cancer (DTC). OBJECTIVE: The current study was designed to analyze whether tumor size at diagnosis is a major prognostic factor in Middle Eastern DTC. METHODS: We conducted a comparative study of the relationship between tumor size at diagnosis and event-free survival (EFS) with...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Thyroid and Parathyroid Surgery
Share to Thyroid Cancer Diagnosis and Treatment
Share to Thyroid Disorders and Treatments

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 39422185
DOI: 10.1210/clinem/dgae740

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The Prognostic Impact of Tumor Size and BRAF Mutational Status in Middle Eastern Differentiated Thyroid CancerPMID 39422185Read ↗

Mutational status may supersede tumor size in predicting the presence of aggressive pathologic features in well differentiated thyroid cancer.Semantic proximity Read ↗

The role of the size in thyroid cancer risk stratification.Semantic proximity Read ↗

BRAF V600E mutation: Differential impact on central lymph node metastasis by tumor size in papillary thyroid carcinoma.Semantic proximity Read ↗

Preoperative BRAF mutation has different predictive values for lymph node metastasis according to tumor size.Semantic proximity Read ↗

Predicting Factors for Bilaterality in Papillary Thyroid Carcinoma with Tumor Size <4 cm.Semantic proximity Read ↗

Impact of clinical risk scores and BRAF V600E mutation status on outcome in papillary thyroid cancer.Semantic proximity Read ↗

The association between BMI and BRAFV600E mutation may differ by primary tumor size.Semantic proximity Read ↗

Impact of BRAF V600E Mutation on Surgical Management and Outcomes in Low-Risk Differentiated Thyroid Carcinoma (T1–2N0M0)Semantic proximity Read ↗

BRAFV600E mutation in fine-needle aspiration aspirates: Association with poorer prognostic factors in larger papillary thyroid carcinomas.Semantic proximity Read ↗

Prognostic Significance of COX-2 Overexpression in BRAF-Mutated Middle Eastern Papillary Thyroid Carcinoma.Semantic proximity Read ↗

Influence of Chronic Lymphocytic Thyroiditis and BRAF V600E Mutation on Clinicopathological Features in Papillary Thyroid Carcinoma With Different Tumor Size.Semantic proximity Read ↗

Clinicopathological characteristics including BRAF V600E mutation status and PET/CT findings in papillary thyroid carcinoma.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.